Cleared Traditional

K180236 - VR Medical Feeding Tube and Enteral Feeding Extension Set (EFES) (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180236 · Vr Medical Technology Co., Ltd. · Gastroenterology & Urology device
Jan 2019
Decision
354d
Days
Class 2
Risk

K180236 is an FDA 510(k) clearance for the VR Medical Feeding Tube and Enteral Feeding Extension Set (EFES). Classified as Tube, Feeding (product code FPD), Class II - Special Controls.

Submitted by Vr Medical Technology Co., Ltd. (Zhouzhuang, CN). The FDA issued a Cleared decision on January 18, 2019 after a review of 354 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5980 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

Submission Details

510(k) Number K180236 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2018
Decision Date January 18, 2019
Days to Decision 354 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
198d slower than avg
Panel avg: 156d · This submission: 354d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPD Tube, Feeding
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5980
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.